National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -5 of 5         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Prevention


Active


12 to 15


Pharmaceutical / Industry


106636
NCT00534638


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Prevention


Approved-not yet active


10 and over


Pharmaceutical / Industry


108160
NCT00730847


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Biomarker/Laboratory analysis, Prevention


Active


10 to 25


Pharmaceutical / Industry


106069
NCT00481767


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Biomarker/Laboratory analysis, Prevention


Active


9 to 15


Pharmaceutical / Industry


111507
NCT00652938


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Prevention


Active


18 to 25


Pharmaceutical / Industry


107863
NCT00586339

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov